✦ LIBER ✦

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy

✍ Scribed by Peter E. Clark; M. Craig Hall; Lester S. Borden Jr; Antonius A. Miller; Jennifer J. Hu; W. Robert Lee; Diana Stindt; Ralph D’Agostino Jr; James Lovato; Michelle Harmon; Frank M. Torti

Book ID: 116945700
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 107 KB
Volume: 67
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2005.12.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of imatinib mesylate in

A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy

✍ Amy M. Lin; Brian I. Rini; Vivian Weinberg; Kristen Fong; Charles J. Ryan; Jonat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Long-term Follow-up of a Phase II Trial

Long-term Follow-up of a Phase II Trial of Chemotherapy Plus Hormone Therapy for Biochemical Relapse After Definitive Local Therapy for Prostate Cancer

✍ Nakabayashi, Mari; Xie, Wanling; Buckle, Geoffrey; Bubley, Glenn; Ernstoff, Marc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Re: Long-Term Follow-up of a Phase II Tr

Re: Long-Term Follow-up of a Phase II Trial of Chemotherapy plus Hormone Therapy for Biochemical Relapse after Definitive Local Therapy for Prostate Cancer

✍ Taneja, Samir S. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 90 KB

Phase II Study of Imatinib Mesylate in P

Phase II Study of Imatinib Mesylate in Patients with Prostate Cancer with Evidence of Biochemical Relapse After Definitive Radical Retropubic Prostatectomy or Radiotherapy

✍ Gopal K. Bajaj; Zhe Zhang; Elizabeth Garrett-Mayer; Renee Drew; Victoria Sinibal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 182 KB

122 A phase-II Trial of intermittent and

122 A phase-II Trial of intermittent androgen ablation in patients presenting biochemical failure after definitive radiotherapy for localized prostate cancer

✍ F. Cury; L. Souhami; R. Rajan; S. Tanguay; M. Duclos; G. Shenouda; B. Gagnon; S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 236 KB

A phase I/II dose-escalation study of ex

A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer

✍ Christopher W. Ryan; Walter M. Stadler; Nicholas J. Vogelzang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB